Anti-inflammatory and anti-nociceptive effects of the methanol extract of Fomes fomentarius

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 10, 2004, Pages 1588-1593

  Park, Young Mi ^a   Kim, In Tae ^a   Park, Hee Juhn ^b   Choi, Jong Won ^c   Park, Kun Young ^d   Lee, Jae Dong ^d   Nam, Byung Hyouk ^d   Kim, Deog Gon ^a   Lee, Jin Yong ^a   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Sangji University   (South Korea)

^c Kyungsung University   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Anti inflammatiory; Anti nociceptive; Fomes fomentarius; Nitric oxide; Nuclear factor B

Indexed keywords

ACETIC ACID; ACETYLSALICYLIC ACID; CARRAGEENAN; CYCLOOXYGENASE 2; FOMES FOMENTARIUS EXTRACT; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; METHANOL; MORPHINE SULFATE; NATURAL PRODUCT; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PROSTAGLANDIN F2 ALPHA;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; FOMES FOMENTARIUS; HOT PLATE TEST; IN VIVO STUDY; INHIBITION KINETICS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PAIN; PAW EDEMA; POLYPORACEAE; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT; WRITHING TEST; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; DOSE RESPONSE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE; PLANT EXTRACTS; POLYPORACEAE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21644490342     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1588     Document Type: Article

References (29)

1. Saar M., J. Ethnopharmacol., 31, 175-179 (1991).
2. Ito H., Sugiura M., Miyazaki T., Chem. Pharm. Bull., 24, 2575 (1976).
3. Michiko A., Motomu T., Atsushi F., Tadaharu H., Susumu K., Michiyo T., Kuniaki O., Yoichi M., Biosci. Biotech. Biochem., 57, 278-282 (1993).
4. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhauser C., J. Biol. Chem., 276, 32008-32015 (2001).
5. Clancy R. M., Abramson S. B., Proc. Soc. Exp. Biol. Med., 210, 93-101 (1995).
6. Attiga F. A., Fernandez P. M., Weeraratna A. T., Manyak M. J., Patierno S. R., Cancer Res., 60, 4629-4637 (2000).
7. Crew T. E., Elder D. J., Paraskeva C., Carcinogenesis, 21, 69-77 (2000).
8. Kwon G., Xu G., Marshall C. A., McDaniel M. L., Biol. Chem., 274, 18702-18708 (1999).
9. Makarov S. S., Mol. Med. Today., 6, 441-448 (2000).
10. Ghosh S., May M. J., Kopp E. B., Annu. Rev. Immunol., 16, 225-260 (1998).
11. Karin M., J. Biol. Chem., 274, 27339-27342 (1999).
12. Zhu H., Qu F., Zhu L. H., Nucleic Acids Res., 21, 5279-5280 (1993).
13. Gragam G. C., Mayer P., Henry R. J., Biotechniques, 16, 48-50 (1994).
14. Fritz H., Trautschold I., Werle E., Hoppe Seyler Z. Physiol. Chem., 342, 253-263 (1965).
15. Eddy N. B., Leimback D., J. Pharmacol. Exp. Ther., 107, 385-393 (1953).
16. Whittle B. A., Br. J. Pharmacol., 22, 446-460 (1949).
17. Carvalho J. C., Silva M. F., Maciel M. A., Pinto A. C., Nunes D. S., Lima R. M., Bastos J. K., Sarti S. J., Planta Med., 62, 402-404 (1996).
18. Green L. C., Wagner D. A., Glogowsky J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Anal. Biochem., 126, 131-138 (1982).
19. Kim R. G., Shin K. M., Kim Y. G., Jeong H. J., Ha J. H., Choi J. W., Park H. J., Lee K. T., Biol. Pharm. Bull., 26, 481-486 (2003).
20. Baeuerle P. A., Cell, 95, 729-731 (1998).
21. Taylor J., Bruns T., White T., "Fourth International Mycological Congress Abstracts," ed. by Reisinger A., Bresinsky A., Botanical Institute. Univ. of Regensbyrg, Germany, 1990, p. 343.
22. Laskin D. L., Pendino K. J., Annu. Rev. Pharmacol. Toxicol., 35, 655-677 (1995).
23. Murakami M., Nakatani Y., Tanioka T., Kudo I., Prostaglandins Other Lipid Mediat., 68-69, 383-399 (2002).
24. Watkins L. R., Maier S. F., Goehler L. E., Pain, 63, 289-302 (1995).
25. Lawrence T., Gilroy D. W., Colville-Nash P. R., Willoughby D. A., Nat. Med., 7, 1291-1297 (2001).
26. Renard P., Raes M., Cell Biol. Toxicol., 15, 341-344 (1999).
27. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., Sakaguchi T., Sawa Y., Morishita R., Kiyono H., Noguchi K., Mashimo T., Neuroreport, 12, 2079-2084 (2001).
28. Tegeder I., Niederberger E., Schmidt R., Kunz S., Guhring H., Ritzeler O., Michaelis M., Geisslinger G., J. Neurosci., 24, 1637-1645 (2004).
29. Koppert W., Wehrfritz A., Korber N., Sittl R., Albrecht S., Schuttler J., Schmelz M., Pain, 108, 148-153 (2004).